(Q28254421)

English

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

scientific article

In more languages

Statements

scholarly article

0 references

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation (English)

0 references

0 references

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

author name string

P Corradini

1

0 references

C Tarella

2

0 references

F Zallio

3

0 references

A Dodero

4

0 references

M Zanni

5

0 references

P Valagussa

6

0 references

A M Gianni

7

0 references

A Rambaldi

8

0 references

T Barbui

9

0 references

S Cortelazzo

10

0 references

language of work or name

0 references

publication date

September 2006

0 references

0 references

20

0 references

9

0 references

1533-8

0 references

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

21 January 2018

Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

7 January 2021

based on heuristic

inferred from DOI database lookup

Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

7 January 2021

based on heuristic

inferred from DOI database lookup

Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404306

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254421&oldid=2175157176"